Cette page est disponible uniquement en anglais

Deal or Case news
01.09.2025
NautaDutilh, working together with Weil, Gotshal & Manges LLP, is advising Morgan Stanley and MUFG, as the joint lead arrangers and bookrunners, for a EUR 16.2 billion bridge credit facility in support of Keurig Dr Pepper Inc.’s acquisition of JDE Peet's. After the acquisition closes, Keurig Dr Pepper Inc. plans to separate into two independent, U.S.-listed publicly traded companies pursuant to a proposed tax-free spin-off of its global coffee business.

Keurig Dr Pepper is a leading beverage company in North America, with a portfolio of more than 125 owned, licensed and partner brands and powerful distribution capabilities to provide a beverage for every need, anytime, anywhere. Their brands include Keurig®, Dr Pepper®, Canada Dry®, Mott's®, A&W®, Peñafiel®, Snapple®, 7UP®, Green Mountain Coffee Roasters®, GHOST®, Clamato®, Core Hydration® and The Original Donut Shop®.

JDE Peet’s is the world's leading pure-play coffee company, serving approximately 4,400 cups of coffee per second in more than 100 markets, with a portfolio of strong iconic brands including Peet’s, L’OR, Jacobs, Douwe Egberts, Kenco, Pilao, OldTown, Super and Moccona.

The NautaDutilh deal team was led by New York-based Dutch Finance Partner Boudewijn Smit and Amsterdam-based Corporate M&A Partner Willem Bijveld, Finance Partner Jinne van Belle and Tax Partner Nina Kielman. Other team members included Jochem Polderman, Dirk Panis, Joppe Schoute, Meliha Dacic, and Beike Baaijens.

Notification de cookies

Cette fonctionnalité utilise des cookies tiers. Modifiez votre cookie préférences pour visualiser ce contenu ou afficher plus d'informations.
Ces cookies assurent le bon fonctionnement du site. Ces cookies ne peuvent pas être désactivés.
Ces cookies peuvent être placés par des tiers, tels que YouTube ou Vimeo.
En désactivant certaines catégories, les fonctionnalités associées au sein du site risquent de ne plus fonctionner correctement. Vous pouvez modifier vos préférences ultérieurement. Voir plus d'informations.